scispace - formally typeset
N

Nahla B Gadalla

Researcher at University of London

Publications -  20
Citations -  988

Nahla B Gadalla is an academic researcher from University of London. The author has contributed to research in topics: Plasmodium falciparum & Population. The author has an hindex of 14, co-authored 19 publications receiving 881 citations. Previous affiliations of Nahla B Gadalla include National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Polymorphisms in Plasmodium falciparum chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine

Meera Venkatesan, +67 more
TL;DR: Monitoring selection and responding to emerging signs of drug resistance are critical tools for preserving efficacy of artemisinin combination therapies; determination of the prevalence of at least pfcrt K76T and pfmdr1 N86Y should now be routine.
Journal ArticleDOI

Directional Selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu Loci of Plasmodium falciparum in Kenyan Children Treated With ACT

TL;DR: Among treated children in western Kenya, certain P. falciparum genotypes defined at pfcrt, pfmdr1, pfap2mu, and pfubp1 more often survive ACT at the submicroscopic level, and contribute to onward transmission and subsequent patent recrudescence.
Journal ArticleDOI

The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.

Nicholas M. Anstey, +133 more
TL;DR: The recommended dose of artemether-lumefantrine provides reliable efficacy in most patients with uncomplicated malaria, however, therapeutic efficacy was lowest in young children from Asia and young underweight children from Africa; a higher dose regimen should be assessed in these groups.
Journal ArticleDOI

Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine

TL;DR: Molecular markers for surveillance of Plasmodium falciparum resistance to current antimalarials are sorely needed and pfmdr1 gene amplification in parasites prior to treatment occurred in three individuals who had recurrent infection during follow-up.